Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil foam versus solution in women with androgenetic alopecia
2008-001770-33Phase 3Completed
- Sponsor
- Klinik für Dermatologie, Venerologie und Allergologie
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Klinik für Dermatologie, Venerologie und Allergologie. Primary endpoints: Change in target area non-vellus hair count, Change in cumulative non-vellus hair width and 1 more. Started Apr 2008; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2008-001770-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001770-33.